Status:
COMPLETED
Zinc Plus Saccharomyces Boulardii Versus Zinc Alone in the Treatment of Acute Diarrhea
Lead Sponsor:
Muhammad Aamir Latif
Conditions:
Acute Watery Diarrhea
Eligibility:
All Genders
1-5 years
Phase:
NA
Brief Summary
In literature combined therapy of zinc with S. boulardii in the treatment of acute diarrhea has not been addressed satisfactorily in the recent past. Therefore, this study was planned aiming to compar...
Detailed Description
Zinc has been used as a recommended choice treating acute watery ailments among children. If any significant beneficial effect in the combined efficacy of zinc with S. boulardii is found, it may add o...
Eligibility Criteria
Inclusion
- Children of either gender
- Aged between 1 month up to 5 years
- Presented with acute diarrhea
Exclusion
- Children with concurrent acute illnesses (meningitis, sepsis, or pneumonia)
- Severe chronic conditions (cystic fibrosis, endocrinopathies, food allergies, or chronic gastrointestinal diseases)
- Severe undernutrition (weight-for-age \<60% of the 50th percentile of CDC 2000 standards)
- Children who used probiotics, antibiotics, or anti-diarrheal drugs within the past 7 days
- The presence of visible blood in stools
Key Trial Info
Start Date :
February 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2025
Estimated Enrollment :
276 Patients enrolled
Trial Details
Trial ID
NCT07168304
Start Date
February 1 2025
End Date
July 31 2025
Last Update
September 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Children's Hospital and The Institute of Child Health
Multan, Punjab Province, Pakistan, 66000